QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
NYSEAMERICAN:NAVB

Navidea Biopharmaceuticals News Headlines

$2.49
+0.19 (+8.26 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.28
Now: $2.49
$2.49
50-Day Range
$1.88
MA: $2.05
$2.27
52-Week Range
$0.63
Now: $2.49
$5.36
Volume248,997 shs
Average Volume265,367 shs
Market Capitalization$66.45 million
P/E RatioN/A
Dividend YieldN/A
Beta1.94

Headlines

Navidea Biopharmaceuticals (NYSEAMERICAN NAVB) News Headlines Today

Source:
SourceHeadline
Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Stock Price Up 8.3%Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Stock Price Up 8.3%
americanbankingnews.com - January 25 at 7:32 PM
Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Trading 9.7% Higher Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Trading 9.7% Higher
americanbankingnews.com - January 12 at 7:36 PM
Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021
finance.yahoo.com - January 7 at 8:10 AM
Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021
finance.yahoo.com - January 7 at 8:10 AM
Head-To-Head Comparison: Navidea Biopharmaceuticals (NYSE:NAVB) & OncoCyte (NYSE:OCX)Head-To-Head Comparison: Navidea Biopharmaceuticals (NYSE:NAVB) & OncoCyte (NYSE:OCX)
americanbankingnews.com - January 1 at 3:10 AM
Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Shares Up 7.5%Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Shares Up 7.5%
americanbankingnews.com - December 31 at 6:54 PM
Navidea Biopharmaceuticals, Inc. (NYSEAMERICAN:NAVB) Director Malcolm G. Witter Acquires 5,000 SharesNavidea Biopharmaceuticals, Inc. (NYSEAMERICAN:NAVB) Director Malcolm G. Witter Acquires 5,000 Shares
americanbankingnews.com - December 31 at 4:27 AM
Navidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm WitterNavidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm Witter
finance.yahoo.com - December 28 at 7:35 AM
New Strong Sell Stocks for December 8thNew Strong Sell Stocks for December 8th
finance.yahoo.com - December 8 at 12:00 PM
Navidea BiopharmaceuticalsNavidea Biopharmaceuticals
fool.com - December 6 at 10:10 PM
Is Navidea Biopharmaceuticals Inc (NAVB) A Good Stock To Buy?Is Navidea Biopharmaceuticals Inc (NAVB) A Good Stock To Buy?
finance.yahoo.com - November 26 at 9:09 PM
AZNs Repurposed COVID-19 Drug Fails, NAVB On Watch, CVAC Rallies On Storage Advantage Of CVnCoVAZN's Repurposed COVID-19 Drug Fails, NAVB On Watch, CVAC Rallies On Storage Advantage Of CVnCoV
nasdaq.com - November 13 at 6:16 AM
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q3 2020 Results - Earnings Call TranscriptNavidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 1:28 AM
Navidea imaging agent shows predictive value in rheumatoid arthritisNavidea imaging agent shows predictive value in rheumatoid arthritis
seekingalpha.com - November 12 at 6:02 PM
Navidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study in Rheumatoid ArthritisNavidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study in Rheumatoid Arthritis
finance.yahoo.com - November 12 at 6:02 PM
Navidea Biopharmaceuticals Reports Third Quarter and Year-to-Date 2020 Financial ResultsNavidea Biopharmaceuticals Reports Third Quarter and Year-to-Date 2020 Financial Results
finance.yahoo.com - November 12 at 6:02 PM
Navidea Biopharmaceuticals to Host Third Quarter 2020 Earnings Conference Call and Corporate UpdateNavidea Biopharmaceuticals to Host Third Quarter 2020 Earnings Conference Call and Corporate Update
finance.yahoo.com - November 5 at 6:53 PM
Navidea Biopharma (NAVB) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseNavidea Biopharma (NAVB) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 29 at 2:13 PM
Navidea Biopharmaceuticals to Present at the Virtual Investor KOL RoundtableNavidea Biopharmaceuticals to Present at the Virtual Investor KOL Roundtable
finance.yahoo.com - October 22 at 7:35 AM
Navidea Biopharmas lead asset data to be presented in an upcoming Rheumatology meetNavidea Biopharma's lead asset data to be presented in an upcoming Rheumatology meet
seekingalpha.com - October 9 at 12:43 PM
Navidea to ring opening bell at NYSENavidea to ring opening bell at NYSE
bizjournals.com - September 28 at 6:18 PM
Navidea Biopharmaceuticals: Too Many Risks InvolvedNavidea Biopharmaceuticals: Too Many Risks Involved
seekingalpha.com - September 14 at 5:49 PM
Navidea Biopharmaceuticals Wins Dismissal of Platinum Loan LitigationNavidea Biopharmaceuticals Wins Dismissal of Platinum Loan Litigation
finance.yahoo.com - September 2 at 5:39 PM
Breakeven On The Horizon For Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)Breakeven On The Horizon For Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)
finance.yahoo.com - August 24 at 5:45 PM
Navidea Biopharmaceuticals to Present at The LD 500 Virtual Investor ConferenceNavidea Biopharmaceuticals to Present at The LD 500 Virtual Investor Conference
finance.yahoo.com - August 24 at 5:45 PM
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q2 2020 Results - Earnings Call TranscriptNavidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 11:51 PM
Navidea Biopharmaceuticals Reports Second Quarter and Year-to-Date 2020 Financial ResultsNavidea Biopharmaceuticals Reports Second Quarter and Year-to-Date 2020 Financial Results
finance.yahoo.com - August 13 at 5:53 PM
Jubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization PartnershipJubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization Partnership
finance.yahoo.com - August 10 at 9:27 AM
Navidea Biopharma secures $25M of committed equity financingNavidea Biopharma secures $25M of committed equity financing
seekingalpha.com - August 10 at 9:07 AM
Navidea Biopharmaceuticals Signs Binding Framework for Commercialization Partnership with Jubilant RadiopharmaNavidea Biopharmaceuticals Signs Binding Framework for Commercialization Partnership with Jubilant Radiopharma
finance.yahoo.com - August 10 at 9:07 AM
Navidea Biopharmaceuticals to Host Second Quarter 2020 Earnings Conference Call and Corporate UpdateNavidea Biopharmaceuticals to Host Second Quarter 2020 Earnings Conference Call and Corporate Update
finance.yahoo.com - August 6 at 5:24 PM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Navidea Biopharmaceuticals, Inc. for Potential Breach of Fiduciary Duty ClaimsINVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Navidea Biopharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - August 5 at 7:51 AM
Is the Options Market Predicting a Spike in Navidea Biopharmaceuticals (NAVB) Stock?Is the Options Market Predicting a Spike in Navidea Biopharmaceuticals (NAVB) Stock?
finance.yahoo.com - June 17 at 12:54 PM
Navidea Biopharmaceuticals Announces Full Enrollment in its Ongoing Phase 2B Trial of Tc99m Tilmanocept in Rheumatoid Arthritis (RA)Navidea Biopharmaceuticals Announces Full Enrollment in its Ongoing Phase 2B Trial of Tc99m Tilmanocept in Rheumatoid Arthritis (RA)
finance.yahoo.com - June 15 at 9:49 AM
Navidea Biopharmaceuticals to Present at the Virtual Investor Fireside Chat SeriesNavidea Biopharmaceuticals to Present at the Virtual Investor Fireside Chat Series
finance.yahoo.com - June 9 at 8:56 AM
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) CongressNavidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress
finance.yahoo.com - June 3 at 8:38 AM
Why This Rheumatoid Arthritis Study Is Huge for Navidea BiopharmaWhy This Rheumatoid Arthritis Study Is Huge for Navidea Biopharma
247wallst.com - May 22 at 2:56 PM
Navidea Bio up big on positive Tc99m tilmanocept data in rheumatoid arthritisNavidea Bio up big on positive Tc99m tilmanocept data in rheumatoid arthritis
seekingalpha.com - May 22 at 9:43 AM
Thinking about buying stock in Navidea Biopharmaceuticals, Aurora Cannabis, Under Armour, Onconova Therapeutics, or BJs Wholesale Club?Thinking about buying stock in Navidea Biopharmaceuticals, Aurora Cannabis, Under Armour, Onconova Therapeutics, or BJs Wholesale Club?
www.prnewswire.com - May 22 at 9:43 AM
Navidea Biopharmaceuticals stock rockets toward 13-month high on heavy volume after update trial dataNavidea Biopharmaceuticals stock rockets toward 13-month high on heavy volume after update trial data
finance.yahoo.com - May 22 at 9:43 AM
Navidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid ArthritisNavidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis
finance.yahoo.com - May 21 at 6:04 PM
Edited Transcript of NAVB earnings conference call or presentation 14-May-20 9:00pm GMTEdited Transcript of NAVB earnings conference call or presentation 14-May-20 9:00pm GMT
finance.yahoo.com - May 15 at 8:00 AM
Navidea Biopharmaceuticals Reports First Quarter 2020 Financial ResultsNavidea Biopharmaceuticals Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 7:36 PM
Navidea regains European rights to LymphoseekNavidea regains European rights to Lymphoseek
seekingalpha.com - May 11 at 5:47 PM
Navidea Biopharmaceuticals to Host First Quarter 2020 Earnings Conference Call and Corporate UpdateNavidea Biopharmaceuticals to Host First Quarter 2020 Earnings Conference Call and Corporate Update
finance.yahoo.com - May 7 at 7:26 AM
Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of DirectorsNavidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors
www.bloomberg.com - May 4 at 5:29 PM
Navidea stays on development track amid pandemic; shares up 4%Navidea stays on development track amid pandemic; shares up 4%
seekingalpha.com - April 22 at 2:29 PM
Navidea Biopharmaceuticals Provides Statement Regarding COVID-19 PandemicNavidea Biopharmaceuticals Provides Statement Regarding COVID-19 Pandemic
finance.yahoo.com - April 22 at 9:04 AM
What You Must Know About Navidea Biopharmaceuticals, Inc.s (NYSEMKT:NAVB) Beta ValueWhat You Must Know About Navidea Biopharmaceuticals, Inc.'s (NYSEMKT:NAVB) Beta Value
finance.yahoo.com - April 21 at 1:02 PM
What You Must Know About Navidea Biopharmaceuticals, Inc.'s (NYSEMKT:NAVB) Beta ValueWhat You Must Know About Navidea Biopharmaceuticals, Inc.'s (NYSEMKT:NAVB) Beta Value
finance.yahoo.com - April 21 at 1:02 PM
This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.